Erchonia Lasers Ltd. products

Erchonia’s non-thermal lasers are the only Low-Level Laser Therapy (LLLT) devices to be FDA Market Cleared for treating toenail and nail fungus (onychomycosis). The efficacy of our machines has been proven by multiple (level 1) double blind, randomised, placebo-controlled, and multi-site clinical studies – the most credible research in the market today. The treatments are short, effective, and automated, allowing you to save on staff costs and increase profits. There is no associated pain or reported side effects, and the technology is very safe with no health risks. We provide the training, ongoing support, and marketing, so you can focus on what matters most – your clients.

New in series: The EVRL® Laser is a cordless handheld device with a simple graphic interface and preset / customisable protocols. EVRL® has the same properties and mechanisms of action as its predecessor, XLR8®, but the addition of a violet wavelength allows the device to treat a larger variety of conditions (e.g. bacterial, fungal, or viral infections).

With the Base Station, you can choose three lasers from XLR8® and EVRL® (e.g. two XLR8® and one EVRL® – the best of both worlds). This combination allows you to treat multiple patients simultaneously, and / or to carry out advanced protocols on patients by using multiple lasers on several different points of the body at the same time.

The XLR8® Laser is a cordless handheld device with a simple graphic interface and preset / customisable protocols. It is the only LLLT device to be FDA Market Cleared for treating chronic / acute back, neck, and shoulder pain, and pain associated with surgery.

The FX 635® Laser is Erchonia’s flagship device for pain relief. It is the only LLLT machine to be FDA Market Cleared for chronic heel pain arising from plantar fasciitis, and chronic low back pain of musculoskeletal origin.